Lakefront Biotherapeutics (LKFT) Net Margin Growth (1y) (2015 - 2026)

Lakefront Biotherapeutics (LKFT) Net Margin Growth (1y) (2015 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin Growth (1y) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1,491.00
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 1,120.00
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -653.00
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 447.00
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Lakefront Biotherapeutics 1.85 Bn -1.64 Bn 1.91 Mn 42,821.00

Historic Data

Download Data
DateValue
Mar 31, 2026 42,821.00
Dec 31, 2025 -13,324.00
Sep 30, 2025 2,934.00
Jun 30, 2025 1,556.00
Mar 31, 2025 -34,911.00
Dec 31, 2024 7,976.00
Sep 30, 2024 -6,893.00
Jun 30, 2024 -2,603.00
Mar 31, 2024 10,489.00
Dec 31, 2023 25,493.00
Sep 30, 2023 -4,352.00
Jun 30, 2023 9,914.00
Mar 31, 2023 13,198.00
Dec 31, 2022 -9,055.00
Sep 30, 2022 260,706.00
Jun 30, 2022 -4,463.00
Mar 31, 2022 -9,237.00
Dec 31, 2021 937.00
Sep 30, 2021 -247,074.00
Jun 30, 2021 6,949.00